Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lymphoma
Interventions: DEVICE: PARASYM neuromodulation device|DEVICE: PARASYM neuromodulation device
Sponsor: University of Oklahoma